Fordham Law School Professor George Conk spoke to the Minneapolis Star-Tribune about a lawsuit complicating Medtronic’s acquisition of Covidien.
“You’re really building your case on the literature,” said Fordham law professor George Conk, who wrote legal briefs in a high-profile product liability case involving the drug Vioxx.
Conk said the discovery of facts that Tunheim has allowed in the new shareholders’ suit could put Medtronic “at very substantial risk.”
Read the entire article here.